Cargando…
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
After the introduction of trastuzumab, a monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2), the overall survival (OS) among patients with HER2-positive breast cancer has been substantially improved. However, among these patients, the incidence of brain metastases (BM)...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627687/ https://www.ncbi.nlm.nih.gov/pubmed/29063053 http://dx.doi.org/10.1016/j.cdtm.2017.01.004 |